Tumor-specific EphA2 receptor tyrosine kinase inhibits anti-tumor immunity by recruiting suppressive myeloid populations in NSCLC

MLA

Jun-Song Chen, et al. Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in NSCLC. May 2020. EBSCOhost, https://doi.org/10.1101/2020.05.08.084830.

APA

Jun-Song Chen, Shan Wang, Dana M. Brantley-Sieders, Wen-Liang Song, & Eileen Shiuan. (2020). Tumor-specific EphA2 receptor tyrosine kinase inhibits anti-tumor immunity by recruiting suppressive myeloid populations in NSCLC. https://doi.org/10.1101/2020.05.08.084830

Chicago

Jun-Song Chen, Shan Wang, Dana M. Brantley-Sieders, Wen-Liang Song, and Eileen Shiuan. 2020. “Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in NSCLC,” May. doi:10.1101/2020.05.08.084830.